Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 8473

1.

Inhibition of ERK1/2 Restores GSK3β Activity and Protein Synthesis Levels in a Model of Tuberous Sclerosis.

Pal R, Bondar VV, Adamski CJ, Rodney GG, Sardiello M.

Sci Rep. 2017 Jun 23;7(1):4174. doi: 10.1038/s41598-017-04528-5.

PMID:
28646232
2.

The genomic landscape of tuberous sclerosis complex.

Martin KR, Zhou W, Bowman MJ, Shih J, Au KS, Dittenhafer-Reed KE, Sisson KA, Koeman J, Weisenberger DJ, Cottingham SL, DeRoos ST, Devinsky O, Winn ME, Cherniack AD, Shen H, Northrup H, Krueger DA, MacKeigan JP.

Nat Commun. 2017 Jun 15;8:15816. doi: 10.1038/ncomms15816.

PMID:
28643795
3.

Genomic rearrangements in sporadic lymphangioleiomyomatosis: an evolving genetic story.

Murphy SJ, Terra SB, Harris FR, Nasir A, Voss JS, Smadbeck JB, Johnson SH, Serla V, Ryu JH, Yi ES, Kipp BR, Vasmatzis G, Carmona EM.

Mod Pathol. 2017 Jun 23. doi: 10.1038/modpathol.2017.52. [Epub ahead of print]

PMID:
28643793
4.

Erzhi Pill® Repairs Experimental Liver Injury via TSC/mTOR Signaling Pathway Inhibiting Excessive Apoptosis.

Zhou BG, Zhao HM, Lu XY, Wang X, Zou Y, Xu R, Yue HY, Liu Y, Zuo ZY, Liu DY.

Evid Based Complement Alternat Med. 2017;2017:5653643. doi: 10.1155/2017/5653643. Epub 2017 May 30.

PMID:
28638431
5.

TFEB activation restores migration ability to Tsc1-deficient adult neural stem/progenitor cells.

Magini A, Polchi A, Di Meo D, Mariucci G, Sagini K, De Marco F, Cassano T, Giovagnoli S, Dolcetta D, Emiliani C.

Hum Mol Genet. 2017 Jun 14. doi: 10.1093/hmg/ddx214. [Epub ahead of print]

PMID:
28637240
6.

Significance of dynamic changes in gastric smooth muscle cell apoptosis, PI3K-AKT-mTOR and AMPK-mTOR signaling in a rat model of diabetic gastroparesis.

Zhang MH, Jiang JZ, Cai YL, Piao LH, Jin Z.

Mol Med Rep. 2017 Jun 13. doi: 10.3892/mmr.2017.6764. [Epub ahead of print]

PMID:
28627597
7.

Two Cases of Tuberous Sclerosis Complex Suggestive of Complicating Multifocal Micronodular Pneumocyte Hyperplasia: A Case Report.

Nishida C, Yatera K, Kido T, Noguchi S, Akata K, Hanaka M, Yamasaki K, Hoshino T, Shimono M, Ishimoto H, Sakamoto N, Mukae H.

J UOEH. 2017;39(2):133-141. doi: 10.7888/juoeh.39.133.

8.

Analysis of genotypes and phenotypes in Chinese children with tuberous sclerosis complex.

Bai D, Zhao J, Li L, Gao J, Wang X.

Sci China Life Sci. 2017 Jun 14. doi: 10.1007/s11427-017-9091-x. [Epub ahead of print]

PMID:
28623545
9.

Neurophysiological evidence of preserved connectivity in tuber tissue.

Kaye HL, Peters JM, Gersner R, Chamberland M, Sansevere A, Rotenberg A.

Epilepsy Behav Case Rep. 2016 Oct 6;7:64-68. doi: 10.1016/j.ebcr.2016.10.001. eCollection 2017.

10.

Primary Intestinal Lymphangiectasia as a First Manifestation of Tuberous Sclerosis Complex.

Tan NBL, Tamblyn S, Hinds R.

J Pediatr Gastroenterol Nutr. 2017 Jun 13. doi: 10.1097/MPG.0000000000001660. [Epub ahead of print] No abstract available.

PMID:
28614114
11.

Downregulation of MicroRNA-193b-3p Promotes Autophagy and Cell Survival by Targeting TSC1/mTOR Signaling in NSC-34 Cells.

Li C, Chen Y, Chen X, Wei Q, Cao B, Shang H.

Front Mol Neurosci. 2017 May 30;10:160. doi: 10.3389/fnmol.2017.00160. eCollection 2017.

12.

The tuberous sclerosis complex gets fatter.

Gokare P, El-Deiry WS.

Oncotarget. 2017 Jun 11. doi: 10.18632/oncotarget.18436. [Epub ahead of print] No abstract available.

13.

Genomics-Guided Precise Anti-Epileptic Drug Development.

Delanty N, Cavallleri G.

Neurochem Res. 2017 Jun 12. doi: 10.1007/s11064-017-2312-y. [Epub ahead of print]

PMID:
28608234
14.

General anaesthesia for caesarean section in a woman with tuberous sclerosis.

Bowditch J, Russell R, McCready S.

Int J Obstet Anesth. 2017 May 5. pii: S0959-289X(17)30153-X. doi: 10.1016/j.ijoa.2017.04.011. [Epub ahead of print] No abstract available.

PMID:
28606653
15.

Improvement in Renal Cystic Disease of Tuberous Sclerosis Complex After Treatment with Mammalian Target of Rapamycin Inhibitor.

Siroky BJ, Towbin AJ, Trout AT, Schäfer H, Thamann AR, Agricola KD, Tudor C, Capal J, Dixon BP, Krueger DA, Franz DN.

J Pediatr. 2017 Jun 6. pii: S0022-3476(17)30636-4. doi: 10.1016/j.jpeds.2017.05.015. [Epub ahead of print]

PMID:
28600153
16.

Dermatological manifestations of tuberous sclerosis complex (TSC).

Ebrahimi-Fakhari D, Meyer S, Vogt T, Pföhler C, Müller CSL.

J Dtsch Dermatol Ges. 2017 Jun 9. doi: 10.1111/ddg.13264. [Epub ahead of print] Review.

PMID:
28598544
17.

Diagnosis of tuberous sclerosis complex in a patient referred for uncontrolled hypertension and renal dysfunction: a case highlighting the importance of proper diagnostic work-up of hypertensive patients.

Sarafidis PA, Bikos A, Loutradis C, Tzikas S, Vakirlis E, Avdelidou E, Zafeiriou D, Papagianni A, Vassilikos V.

J Hypertens. 2017 Jun 7. doi: 10.1097/HJH.0000000000001423. [Epub ahead of print]

PMID:
28594706
18.

BRSK2 induced by nutrient deprivation promotes Akt activity in pancreatic cancer via downregulation of mTOR activity.

Saiyin H, Na N, Han X, Fang Y, Wu Y, Lou W, Yang X.

Oncotarget. 2017 May 18. doi: 10.18632/oncotarget.17965. [Epub ahead of print]

19.

Novel case of resolution of hypsarrhythmia following tuber resection in a patient with infantile spasms and tuberous sclerosis.

Marsh R, Nichols C, Payne M.

Clin Case Rep. 2017 Apr 19;5(6):859-862. doi: 10.1002/ccr3.780. eCollection 2017 Jun.

20.

Effects of Gui Zhu Yi Kun formula on the P53/AMPK pathway of autophagy in granulosa cells of rats with polycystic ovary syndrome.

Xing Y, Liu YX, Liu X, Wang SL, Li P, Lin XH, Sui CL, Xu C, Qi B, Tong Q.

Exp Ther Med. 2017 Jun;13(6):3567-3573. doi: 10.3892/etm.2017.4384. Epub 2017 Apr 26.

Supplemental Content

Loading ...
Support Center